ERK signalling: a master regulator of cell behaviour, life and fate.

Nat Rev Mol Cell Biol

Laboratory of Intracellular Signalling, Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada.

Published: October 2020

AI Article Synopsis

  • ERK1 and ERK2 are key proteins in a signaling pathway that transmits growth signals, primarily influenced by RAS GTPases, and play a crucial role in various cellular functions.
  • Dysregulation of these ERK proteins can lead to various human diseases, making their study important in understanding cellular processes.
  • The review explores the structure, regulatory mechanisms, and functions of ERK1 and ERK2, highlighting their involvement in essential processes like cell proliferation, survival, growth, metabolism, migration, and differentiation.

Article Abstract

The proteins extracellular signal-regulated kinase 1 (ERK1) and ERK2 are the downstream components of a phosphorelay pathway that conveys growth and mitogenic signals largely channelled by the small RAS GTPases. By phosphorylating widely diverse substrates, ERK proteins govern a variety of evolutionarily conserved cellular processes in metazoans, the dysregulation of which contributes to the cause of distinct human diseases. The mechanisms underlying the regulation of ERK1 and ERK2, their mode of action and their impact on the development and homeostasis of various organisms have been the focus of much attention for nearly three decades. In this Review, we discuss the current understanding of this important class of kinases. We begin with a brief overview of the structure, regulation, substrate recognition and subcellular localization of ERK1 and ERK2. We then systematically discuss how ERK signalling regulates six fundamental cellular processes in response to extracellular cues. These processes are cell proliferation, cell survival, cell growth, cell metabolism, cell migration and cell differentiation.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41580-020-0255-7DOI Listing

Publication Analysis

Top Keywords

erk1 erk2
12
erk signalling
8
cellular processes
8
cell
7
signalling master
4
master regulator
4
regulator cell
4
cell behaviour
4
behaviour life
4
life fate
4

Similar Publications

Aims: This study aimed to delineate the effect of hyperglycemia on the Alu/LINE-1 hypomethylation and in ERK1/2 genes expression in type 2 diabetes with and without cataract.

Methods: This study included 58 diabetic patients without cataracts, 50 diabetic patients with cataracts, and 36 healthy controls. After DNA extraction and bisulfite treatment, LINE-1 and Alu methylation levels were assessed using Real-time MSP.

View Article and Find Full Text PDF

Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.

Nat Med

January 2025

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

The MEK inhibitor selumetinib induces objective responses and provides clinical benefit in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs). To evaluate whether similar outcomes were possible in adult patients, in whom PN growth is generally slower than in pediatric patients, we conducted an open-label phase 2 study of selumetinib in adults with NF1 PNs. The study was designed to evaluate objective response rate (primary objective), tumor volumetric responses, patient-reported outcomes and pharmacodynamic effects in PN biopsies.

View Article and Find Full Text PDF
Article Synopsis
  • Monkeypox (Mpox) is increasingly recognized as a public health issue, and this study uses multi-omics approaches to find therapeutic targets and drug repurposing opportunities to understand its molecular mechanisms.
  • Researchers created a host-pathogen interaction network and identified 55 differentially expressed genes related to Mpox, pinpointing 16 potential drug targets that include both proviral and antiviral genes involved in critical signaling pathways.
  • Promising FDA-approved drug candidates, such as kinase inhibitors and Niclosamide, were identified, aiming to enhance treatment strategies and further the understanding of Mpox's pathology.
View Article and Find Full Text PDF

Transfer RNA-derived fragment production in calves challenged with or co-infected with bovine viral diarrhea virus and in several tissues and blood.

Front Vet Sci

November 2024

Ruminant Diseases and Immunology Research Unit, National Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Ames, IA, United States.

Understanding the molecular mechanisms underlying immune response can allow informed decisions in drug or vaccine development, and aid in the identification of biomarkers to predict exposure or evaluate treatment efficacy. The objective of this study was to identify differentially expressed transfer RNA-derived fragments (tRFs) in calves challenged with () or co-infected with and bovine viral diarrhea virus (BVDV). Serum, white blood cells (WBC), liver, mesenteric lymph node (MLN), tracheal-bronchial lymph node (TBLN), spleen, and thymus were collected from Control ( = 2), (MB;  = 3), and co-infected (Dual; = 3) animals, and small RNAs extracted for sequencing.

View Article and Find Full Text PDF
Article Synopsis
  • Multiple myeloma (MM) is a type of blood cancer marked by excessive production of plasma cells that release antibodies, and current research on treatments like Raddeanin A (RA) focuses mainly on solid tumors, leaving a gap in understanding its effects on MM specifically.
  • RA, derived from Anemone raddeana regel, shows promising anti-tumor effects, and this study explores how it may inhibit MM cell growth through network pharmacology and experimental methods, revealing significant interactions with the MAPK signaling pathway.
  • Experimental results demonstrate that RA effectively slows MM cell proliferation, induces apoptosis, alters mitochondrial function, and impacts the expression of key proteins involved in cell growth and survival, suggesting a powerful potential for RA as a treatment for multiple my
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!